Corcept presents survival data for ovarian cancer drug Lifyorli
Go back to Corcept presents survival data for ovarian cancer drug Lifyorli| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 81.37 +1.52 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.85 | 52 Week High | $10.00 | |||
| Open | $80.56 | 52 Week Low | $3.22 | |||
| Day High | $81.62 | P/E | N/A | |||
| Day Low | $80.48 | EPS | $-0.46 | |||
| Volume | 16,840 | |||||
